TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial
Approval given after Safety Review Committee (SRC) review of safety data from the three patients comprising Cohort 2 No significant...